# Cymbalta

NDC: 0002-3270
Generic name: Duloxetine hydrochloride
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20100115
Marketing ended: 20261002
FDA application: NDA021427

## Active ingredients

- DULOXETINE HYDROCHLORIDE: 60 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-3270"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-3270
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba